Want to be a guest on The Platform podcast? Learn more and submit your application today.
On today's episode of The Platform, we learn about angel and venture investing in the life sciences sector. Randy Thompson, Chairman and CEO of Valhalla Private Capital, gives us a window into the inner workings of venture capital funds and also provides listeners with valuable advice for fundraising in today's business environment.
Read MoreIn this episode of The Platform, Erica chats with Total Brain, a biotech company that has developed tech that shows improvements in mental health and fitness through brain-based self-awareness and training.
Read MoreIn this episode of The Platform, Lise Pape, Founder and Managing Director of Walk With Path joins us to discuss how this new laser shoe technology is paving the way for people living with Parkinson’s Disease. As the company begins to seek investment, you’ll hear about the concept, the numbers, and the opportunity.
Read MoreGlobally, the Coalition for Epidemic Preparedness Innovations (CEPI) has invested more than $23 million US towards the development of a vaccine for COVID-19 and, as of now, it is expected that around 20 companies have potential medicines in various stages of development, with at least four existing medicines now in late phase clinical trials. Meanwhile there are around fifty projects exploring a variety of vaccine technologies, many of them industry/academia collaborations, and the most advanced entering early phase clinical trials... But what does this all mean? And when can we expect to see a vaccine? We chat with Dr. Beatnice Setnik of Altasciences to uncover the timeline and process in getting a vaccine to market.
Read More
